Dr. Rudorfer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6131 Executive Blvd
Rockville, MD 20852Phone+1 301-424-5773Fax+1 240-363-0074- Is this information wrong?
Education & Training
- Clinical Center at the National Institutes of HealthFellowship, Clinical Pharmacology, 1981 - 1983
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 1977 - 1981
- State University of New York Downstate Medical Center College of MedicineClass of 1977
Certifications & Licensure
- MD State Medical License 1981 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 14 citationsLongitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE ...Sarah H. Lisanby, Shawn M. McClintock, William V. McCall, Rebecca G. Knapp, C. Munro Cullum, Martina Mueller, Zhi-De Deng, Abeba A. Teklehaimanot, Matthew V. Rudorfer,...> ;The American Journal of Geriatric Psychiatry. 2021 May 17
- 29 citationsNeurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.Sarah H. Lisanby, Shawn M. McClintock, George S. Alexopoulos, Samuel H. Bailine, Elisabeth Bernhardt, Mimi C. Briggs, C. Munro Cullum, Zhi-De Deng, Mary Dooley, Emma T...> ;The American Journal of Geriatric Psychiatry. 2020 Mar 1
- 42 citationsEffect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.Alastair J. Flint, Barnett S. Meyers, Anthony J. Rothschild, Ellen M. Whyte, George S. Alexopoulos, Matthew V. Rudorfer, Patricia Marino, Samprit Banerjee, Cristina Po...> ;JAMA. 2019 Aug 20
- Join now to see all
Press Mentions
- FDA Overlooked Red Flags in Drugmaker's Testing of New Depression MedicineJune 11th, 2019
- FDA Overlooked Red Flags While Testing New Depression Drug It ApprovedJune 10th, 2019
- Written Exposure Therapy, a Shorter and Cheaper PTSD Treatment, Shows Promising ResultsAugust 10th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: